Curcumin formulations for better bioavailability: what we learned from clinical trials thus far?

M Hegde, S Girisa, B BharathwajChetty, R Vishwa… - ACS …, 2023 - ACS Publications
Curcumin has been credited with a wide spectrum of pharmacological properties for the
prevention and treatment of several chronic diseases such as arthritis, autoimmune …

Improving curcumin bioavailability: Current strategies and future perspectives

R Tabanelli, S Brogi, V Calderone - Pharmaceutics, 2021 - mdpi.com
Curcumin possesses a plethora of interesting pharmacological effects. Unfortunately, it is
also characterized by problematic drug delivery and scarce bioavailability, representing the …

[HTML][HTML] Pharmacological properties and underlying mechanisms of curcumin and prospects in medicinal potential

YS Fu, TH Chen, L Weng, L Huang, D Lai… - Biomedicine & …, 2021 - Elsevier
Curcumin, isolated from Curcuma longa L., is a fat-soluble natural compound that can be
obtained from ginger plant tuber roots, which accumulative evidences have demonstrated …

Role of turmeric and curcumin in prevention and treatment of chronic diseases: Lessons learned from clinical trials

AB Kunnumakkara, M Hegde, D Parama… - ACS Pharmacology & …, 2023 - ACS Publications
Turmeric (Curcuma longa) has been used for thousands of years for the prevention and
treatment of various chronic diseases. Curcumin is just one of> 200 ingredients in turmeric …

Curcumin‐piperine co‐supplementation and human health: a comprehensive review of preclinical and clinical studies

H Heidari, M Bagherniya, M Majeed… - Phytotherapy …, 2023 - Wiley Online Library
Curcumin is extracted from the rhizomes Curcuma longa L. It is known for its anti‐
inflammatory and anti‐oxidant activities. Despite its safety and potential for use against …

Therapeutic effect of curcumin on metabolic diseases: evidence from clinical studies

Y Zeng, Y Luo, L Wang, K Zhang, J Peng… - International Journal of …, 2023 - mdpi.com
Metabolic diseases have become a serious threat to human health worldwide. It is crucial to
look for effective drugs from natural products to treat metabolic diseases. Curcumin, a …

Turmeric and curcumin: from traditional to modern medicine

M Akaberi, A Sahebkar, SA Emami - … on Biomarkers and New Targets in …, 2021 - Springer
The rhizome of turmeric (Curcuma longa L.) has been used as an herbal medicine, coloring
agent, spice, and food additive for thousands of years in different parts of the world …

Curcumae rhizoma and its major constituents against hepatobiliary disease: Pharmacotherapeutic properties and potential clinical applications

TH Gao, W Liao, LT Lin, ZP Zhu, MG Lu, CM Fu, T Xie - Phytomedicine, 2022 - Elsevier
Background Hepatobiliary disease currently serves as an urgent health issue in public due
to health-modulating factors such as extension of life expectancy, increasingly sedentary …

Curcumin supplementation and human disease: a scoping review of clinical trials

TM Panknin, CL Howe, M Hauer… - International Journal of …, 2023 - mdpi.com
Medicinal properties of turmeric (Curcuma longa L.), a plant used for centuries as an anti-
inflammatory, are attributed to its polyphenolic curcuminoids, where curcumin predominates …

Curcumin supplementation improves biomarkers of oxidative stress and inflammation in conditions of obesity, type 2 diabetes and NAFLD: Updating the status of …

K Mokgalaboni, Y Ntamo, K Ziqubu, TM Nyambuya… - Food & function, 2021 - pubs.rsc.org
Oxidative stress and inflammation remain the major complications implicated in the
development and progression of metabolic complications, including obesity, type 2 diabetes …